4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000084
Director sold 1,400 shares at $40.00 ($56,000)
- Director acquired 1,400 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Scadden David · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-07-10 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,400 | $18.09 | $25,326 | 19,003 | D |
| 2025-07-10 | Sale : show line 2 in the form 10b5-1 | −1,400 | $40.00 | $56,000 | 17,603 | D |
| Open-market sales · 1,400 sh · avg $40.00 · $56,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-07-10 | Exercise or conversion : show line 3 in the form 10b5-1 Stock options (right to buy) | −1,400 | 27,707 | D |
Loading xslF345X05/wk-form4_1752609950.xml…